Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ETRM > SEC Filings for ETRM > Form 8-K on 11-May-2009All Recent SEC Filings

Show all filings for ENTEROMEDICS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ENTEROMEDICS INC


11-May-2009

Change in Directors or Principal Officers, Financial Statements and Exhibits


Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

At the 2009 annual meeting of stockholders (the "Annual Meeting") of EnteroMedics Inc. (the "Company") held on May 6, 2009, the Company's stockholders approved an amendment (the "Plan Amendment") of the Company's 2003 Stock Incentive Plan (the "Plan"). The Plan Amendment increased the number of shares authorized for issuance under the Plan by 3,000,000 shares from 3,901,103 to 6,901,103. No other amendments to the Plan were approved by stockholders at the Annual Meeting. The Plan Amendment was previously adopted by the Company's Board of Directors, subject to stockholder approval, and became effective upon the receipt of stockholder approval on May 6, 2009.

The purpose of the Plan is to aid in attracting and retaining employees, management personnel and other personnel and members of the Board of Directors who are not also employees of the Company capable of assuring the future success of the Company, to offer incentives to put forth maximum efforts for the success of the Company's business and to afford those persons an opportunity to acquire a proprietary interest in the Company. The Company's Board of Directors has appointed the Compensation Committee to administer the Plan. As a result, the Compensation Committee has the authority to determine when and to whom awards will be granted, and the type, amount, form of payment and other terms and conditions of each award, consistent with the provisions of the Plan. The Plan authorizes the grant of non-qualified stock options and incentive stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalents, performance awards, stock awards and other stock-based awards. Subject to the provisions of the Plan, the Compensation Committee may amend or waive the terms and conditions, or accelerate the exercisability, of an outstanding award. The Compensation Committee has the authority to interpret the Plan and establish rules and regulations for the administration of the Plan. Any employee, officer, consultant, independent contractor or non-employee director providing services to the Company or any of its affiliates, who is selected by the Compensation Committee, is eligible to receive an award under the Plan. However, only employees of the Company or its subsidiary are eligible for grants of incentive stock options. While the Company's Board of Directors retains the right to terminate the Plan as described above, the Plan will automatically terminate on October 1, 2013, the tenth anniversary of the effective date of the Plan.

The foregoing description of the Plan Amendment is subject to, and qualified in its entirety by reference to, the full text of the Plan, as amended, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by this reference. A more detailed summary of the Plan, as amended, can be found in the Company's Proxy Statement for the Annual Meeting filed with the Securities and Exchange Commission on April 6, 2009.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description
10.1 EnteroMedics Inc. 2003 Stock Incentive Plan, as amended.


  Add ETRM to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ETRM - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.